Intelligent Bio Solutions Stock Price To Earning

INBS Stock

USD 1.61 0.10 6.62%

Intelligent Bio Solutions fundamentals help investors to digest information that contributes to Intelligent Bio's financial success or failures. It also enables traders to predict the movement of Intelligent Stock. The fundamental analysis module provides a way to measure Intelligent Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelligent Bio stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Intelligent Bio Solutions Company Price To Earning Analysis

Intelligent Bio's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Intelligent Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for Intelligent Bio is extremely important. It helps to project a fair market value of Intelligent Stock properly, considering its historical fundamentals such as Price To Earning. Since Intelligent Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intelligent Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intelligent Bio's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Deferred Long Term Liab	Property Plant Equipment	Long Term Debt	Short Term Investments	Intangible Assets
Total Assets		0.97	-0.95	-0.78	0.8	-0.26	0.96	-0.86	-0.13	0.93	0.95	0.95	-0.92	-0.91	0.93	0.55	-0.32	0.5	-0.32	-0.32	-0.35
Total Stockholder Equity	0.97		-0.96	-0.85	0.77	-0.41	0.93	-0.89	-0.18	0.9	0.92	0.99	-0.96	-0.95	0.91	0.67	-0.52	0.55	-0.52	-0.52	-0.54
Net Debt	-0.95	-0.96		0.7	-0.69	0.34	-0.96	0.9	0.26	-0.97	-0.91	-0.95	0.9	0.89	-0.97	-0.64	0.39	-0.35	0.39	0.39	0.41
Retained Earnings	-0.78	-0.85	0.7		-0.65	0.48	-0.66	0.74	-0.01	-0.59	-0.76	-0.86	0.91	0.89	-0.57	-0.78	0.68	-0.82	0.68	0.68	0.71
Accounts Payable	0.8	0.77	-0.69	-0.65		0.01	0.73	-0.67	0.13	0.74	0.78	0.76	-0.76	-0.74	0.7	0.33	-0.17	0.4	-0.17	-0.17	-0.16
Total Liab	-0.26	-0.41	0.34	0.48	0.01		-0.25	0.35	0.47	-0.21	-0.1	-0.43	0.42	0.48	-0.24	-0.65	0.67	-0.4	0.67	0.67	0.68
Total Current Assets	0.96	0.93	-0.96	-0.66	0.73	-0.25		-0.77	-0.08	0.97	0.93	0.89	-0.83	-0.82	0.98	0.53	-0.27	0.27	-0.27	-0.27	-0.29
Short Term Debt	-0.86	-0.89	0.9	0.74	-0.67	0.35	-0.77		0.49	-0.82	-0.81	-0.94	0.93	0.94	-0.81	-0.67	0.43	-0.57	0.43	0.43	0.44
Common Stock	-0.13	-0.18	0.26	-0.01	0.13	0.47	-0.08	0.49		-0.17	0.04	-0.27	0.23	0.31	-0.21	-0.18	0.14	-0.18	0.14	0.14	0.14
Net Receivables	0.93	0.9	-0.97	-0.59	0.74	-0.21	0.97	-0.82	-0.17		0.92	0.88	-0.83	-0.82	0.97	0.56	-0.2	0.18	-0.2	-0.2	-0.2
Net Tangible Assets	0.95	0.92	-0.91	-0.76	0.78	-0.1	0.93	-0.81	0.04	0.92		0.9	-0.89	-0.85	0.88	0.6	-0.3	0.39	-0.3	-0.3	-0.3
Net Invested Capital	0.95	0.99	-0.95	-0.86	0.76	-0.43	0.89	-0.94	-0.27	0.88	0.9		-0.98	-0.98	0.88	0.7	-0.52	0.6	-0.52	-0.52	-0.54
Short Long Term Debt	-0.92	-0.96	0.9	0.91	-0.76	0.42	-0.83	0.93	0.23	-0.83	-0.89	-0.98		1.0	-0.8	-0.77	0.51	-0.67	0.51	0.51	0.52
Capital Stock	-0.91	-0.95	0.89	0.89	-0.74	0.48	-0.82	0.94	0.31	-0.82	-0.85	-0.98	1.0		-0.8	-0.77	0.52	-0.68	0.52	0.52	0.54
Net Working Capital	0.93	0.91	-0.97	-0.57	0.7	-0.24	0.98	-0.81	-0.21	0.97	0.88	0.88	-0.8	-0.8		0.47	-0.26	0.2	-0.26	-0.26	-0.27
Current Deferred Revenue	0.55	0.67	-0.64	-0.78	0.33	-0.65	0.53	-0.67	-0.18	0.56	0.6	0.7	-0.77	-0.77	0.47		-0.61	0.5	-0.61	-0.61	-0.61
Deferred Long Term Liab	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61		-0.58	1.0	1.0	0.99
Property Plant Equipment	0.5	0.55	-0.35	-0.82	0.4	-0.4	0.27	-0.57	-0.18	0.18	0.39	0.6	-0.67	-0.68	0.2	0.5	-0.58		-0.58	-0.58	-0.63
Long Term Debt	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61	1.0	-0.58		1.0	0.99
Short Term Investments	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61	1.0	-0.58	1.0		0.99
Intangible Assets	-0.35	-0.54	0.41	0.71	-0.16	0.68	-0.29	0.44	0.14	-0.2	-0.3	-0.54	0.52	0.54	-0.27	-0.61	0.99	-0.63	0.99	0.99

Click cells to compare fundamentals

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Competition

Predict Intelligent Bio

Intelligent Retained Earnings

Retained Earnings

(49.37 Million)

At this time, Intelligent Bio's Retained Earnings are comparatively stable compared to the past year.

Based on the latest financial disclosure, Intelligent Bio Solutions has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.0% higher than that of the company.

Intelligent Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Bio's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics of similar companies.

Intelligent Bio is currently under evaluation in price to earning category among its peers.

Intelligent Fundamentals

	Return On Equity	-1.72
	Return On Asset	-0.53
	Operating Margin	(3.86) %
	Current Valuation	3.88 M
	Shares Outstanding	4.39 M
	Shares Owned By Insiders	3.01 %
	Shares Owned By Institutions	14.38 %
	Number Of Shares Shorted	420.64 K
	Price To Book	1.16 X
	Price To Sales	2.27 X
	Revenue	3.11 M
	Gross Profit	326.67 K
	EBITDA	(8.81 M)
	Net Income	(10.19 M)
	Cash And Equivalents	8.28 M
	Cash Per Share	0.56 X
	Total Debt	871.44 K
	Current Ratio	2.33 X
	Book Value Per Share	2.41 X
	Cash Flow From Operations	(9.57 M)
	Short Ratio	1.25 X
	Earnings Per Share	(2.30) X
	Target Price	12.0
	Number Of Employees	50
	Beta	4.72
	Market Capitalization	6.14 M
	Total Asset	13.78 M
	Retained Earnings	(51.96 M)
	Working Capital	3.08 M
	Net Asset	13.78 M

About Intelligent Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC